Artificial intelligence in oncology.
Vivosim AI is based on proprietary algorithms which can be used to improve drug dosing strategies along cancer treatment cycles, for higher efficacy and safety in each patient.
Our technology is under development for hematologic cancers.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vivosim.de/
Vivosim Questions
Vivosim's website is http://www.vivosim.de/
Vivosim's LinkedIn profile is https://www.linkedin.com/company/vivosim
Vivosim's industry is
Biotechnology Research
Vivosim's top competitors are
Dna Finance,
The Business Of Biofabrication,
Vivosim Labs, Inc.,
Innyte,
Viscient Bio Inc,
Adarx Pharmaceuticals Inc.,
Comprevie,
Synvivo, Inc,
Hypodia - Bureau Médical Digital Personnalisé,
Daré Bioscience, Inc..
Vivosim's categories are Biotechnology Research
